Can we differentiate between airway and vascular smooth muscle?

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 11, 2004, Pages 805-810

  Fernandes, Darren J ^a,b   McConville, John F ^b   Stewart, Alastair G ^a   Kalinichenko, Vladimir ^b   Solway, Julian ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Airway; Differentiation; Pharmacotherapy; Smooth muscle; Vascular

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR;

ASTHMA; BRONCHOSPASM; CELL DIFFERENTIATION; CONFERENCE PAPER; GENE EXPRESSION REGULATION; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG BLOOD FLOW; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; RNA ANALYSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; RESPIRATORY PHYSIOLOGY; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; STEM CELLS;

EID: 9344251714     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04084.x     Document Type: Conference Paper

References (56)

1. Sparrow MP, Weichselbaum M, McCray PB. Development of the innervation and airway smooth muscle in human fetal lung. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 550-60.
2. Yamada T, Suzuki E, Gejyo F, Ushiki T. Developmental changes in the structure of the rat fetal lung, with special reference to the airway smooth muscle and vasculature. Arch. Histol. Cytol. 2002; 65: 55-69.
3. Weaver M, Batts L, Hogan BL. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev. Biol. 2003; 258: 169-84.
4. Yang Y, Palmer KC, Relan N, Diglio C, Schuger L. Role of laminin polymerization at the epithelial mesenchymal interface in bronchial myogenesis. Development 1998; 125: 2621-9.
5. Yang Y, Relan NK, Przywara DA, Schuger L. Embryonic mesenchymal cells share the potential for smooth muscle differentiation: Myogenesis is controlled by the cell's shape. Development 1999; 126: 3027-33.
6. Jostarndt-Fogen K, Djonov V, Draeger A. Expression of smooth muscle markers in the developing murine lung: Potential contractile properties and lineal descent. Histochem. Cell Biol. 1998; 110: 273-84.
7. Belknap JK, Weiser-Evans MC, Grieshaber SS, Majack RA, Stenmark KR. Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 24-34.
8. Woodcock-Mitchell J, White S. Stirewalt W, Periasamy M, Mitchell J. Low RB. Myosin isoform expression in developing and remodeling rat lung. Am. J. Respir. Cell. Mol. Biol. 1993; 8: 617-25.
9. deMello DE, Sawyer D, Calvin N, Reid LM. Early fetal development of lung vasculature. Am. J. Respir. Cell. Mol. Biol. 1997; 16: 568-81.
10. Shu W, Jiang YQ, Lu MM, Morrisey EE, Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002; 129: 4831-42.
11. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, Minoo P. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev. Dyn. 2000; 217: 180-90.
12. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC. Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem. 2004; 279: 37 124-32.
13. Pepicelli CV, Lewis PM, McMahon AP. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr. Biol. 1998; 8: 1083-6.
14. Hall SM, Hislop AA, Haworth SG. Origin, differentiation, and maturation of human pulmonary veins. Am. J. Respir. Cell. Mol. Biol. 2002; 26: 333-40.
15. Hislop AA. Airway and blood vessel interaction during lung development. J. Anal. 2002; 201: 325-34.
16. Stewart AG, Tomlinson PR, Wilson JW. Regulation of airway wall remodeling. Prospects for the development of novel antiasthma drugs. Adv. Pharmacol. 1995; 33: 209-53.
17. Goncharova EA, Billington CK, Irani C et al. Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am. J. Respir. Cell Mol. Biol. 2003; 29: 19-27.
18. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell. Mol. Biol. 1997; 16: 664-73.
19. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 2003; 171: 380-9.
20. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 2001; 7: 382-3.
21. Stephens NL, Li W, Wang Y, Ma X. The contractile apparatus of airway smooth muscle. Biophysics and biochemistry. Am. J. Respir. Crit. Care Med. 1998; 158 (Suppl.): S80-94.
22. Halayko AJ, Rector E. Stephens NL. Characterization of molecular determinants of smooth muscle cell heterogeneity. Can. J. Physiol. Pharmacol. 1997; 75: 917-29.
23. Halayko AJ, Stephens NL. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma. Can. J. Physiol. Pharmacol. 1994; 72: 1448-57.
24. Moir LM, Leung SY, Eynott PR et al. Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 284: L148-59.
25. Nelander S, Mostad P, Lindahl P. Prediction of cell type-specific gene modules: Identification and initial characterization of a core set of smooth muscle-specific genes. Genome Res. 2003; 13: 1838-54.
26. Low RB, White SL. Lung smooth muscle differentiation. Int. J. Biochem. Cell Biol. 1998; 30: 869-83.
27. Low RB, Mitchell J, Woodcock-Mitchell J, Rovner AS, White SL. Smooth-muscle myosin heavy-chain SM-B isoform expression in developing and adult rat lung. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 651-7.
28. Rensen SS, Thijssen VL, De Vries CJ, Doevendans PA. Detera-Wadleigh SD, Van Eys GJ. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc. Res. 2002; 55: 850-63.
29. Gorenne I, Nakamoto RK, Phelps CP, Beckerle MC, Somlyo AV. Somlyo AP. LPP, a LIM protein highly expressed in smooth muscle. Am. J. Physiol. Cell Physiol. 2003; 285: C674-85.
30. Hsieh CM, Yoshizumi M, Endege WO et al. APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury. J. Biol. Chem. 1996; 271: 17 354-9.
31. Hoggatt AM, Simon GM, Herring BP. Cell-specific regulatory modules control expression of genes in vascular and visceral smooth muscle tissues. Circ. Res. 2002; 91: 1151-9.
32. Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I, Owens GK. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ. Res. 1998; 82: 908-17.
33. Kumar MS, Hendrix JA, Johnson AD, Owens GK. Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ. Res. 2003; 92: 840-7.
34. Regan CP, Manabe I, Owens GK. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Circ. Res. 2000; 87: 363-9.
35. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small JV. The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 1996; 122: 2415-25.
36. Li L, Miano JM, Mercer B, Olson EN. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 1996; 132: 849-59.
37. Xu R, Ho YS, Ritchie RP, Li L. Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H1398-407.
38. Solway J, Forsythe SM, Halayko AJ, Vieira JE, Hershenson MB, Camoretti-Mercado B. Transcriptional regulation of smooth muscle contractile apparatus expression. Am. J. Respir. Crit. Care Med. 1998; 158(Suppl.):S100-8.
39. Miano JM. Serum response factor: Toggling between disparate programs of gene expression. J. Mol. Cell. Cardiol. 2003; 35: 577-93.
40. Norman C, Runswick M, Pollock R, Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 1988; 55: 989-1003.
41. Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 737-47.
42. Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays 2002; 24: 362-70.
43. Manabe I, Owens GK. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J. Clin. Invest. 2001; 107: 823-34.
44. Lilly B, Olson EN, Beckerle MC. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev. Biol. 2001; 240: 531-47.
45. Morrisey EE, Ip HS, Tang Z, Lu MM, Parmacek MS. GATA-5. A transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev. Biol. 1997; 183: 21-36.
46. Kalinichenko VV, Lim L, Stolz DB et al. Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box fl transcription factor. Dev. Biol. 2001; 235; 489-506.
47. McCray Jr PB. Spontaneous contractility of human fetal airway smooth muscle. Am. J. Respir. Cell. Mol. Biol. 1993; 8: 573-80.
48. Schittny JC, Miserocchi G, Sparrow MP. Spontaneous peristaltic airway contractions propel lung liquid through the bronchial tree of intact and fetal lung explants. Am. J. Respir. Cell Mol. Biol. 2000; 23: 11-18.
49. Olsen CR, DeKock MA, Colebatch HJ. Stability of airways during reflex bronchoconstriction. J. Appl. Physiol. 1967; 23: 23-6.
50. Widdicombe JG. Regulation of tracheobronchial smooth muscle. Physiol. Rev. 1963; 43: 1-37.
51. Seow CY, Fredberg JJ. Historical perspective on airway smooth muscle: The saga of a frustrated cell. J. Appl. Physiol. 2001; 91: 938-52.
52. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 1993; 148: 720-6.
53. Johnson PR, Roth M, Tamm M et al. Airway smooth muscle cell proliferation is increased in asthma. Am. J. Respir. Crit. Care Med. 2001; 164: 474-7.
54. Ma X, Cheng Z, Kong H et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 283: L1181-9.
55. Schofer J, Schluter M, Gershlick AH et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-9.
56. Lanza GM, Yu X, Winter PM et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent. Implications for rational therapy of restenosis. Circulation 2002; 106: 2842-7.